ketamine treatment Archives

GLP-1 Providers Can Now Drive New Revenue Streams Through Diagnostic Bundling

The compounded GLP-1 market has become fiercely competitive. Most clinics compete on price and speed. Mindful Labs wants to change that equation entirely. Key Takeaway Details Revenue per patient $40 per consult (three times per year) For every 100 patients You earn $12,000 annually (this is in incremental to medication or visit revenues) Operational lift […]

Texas Medical Board Proposes Sweeping New Rules for Ketamine Clinics

This proposal introduces mandatory registration for clinics and establishes strict standards for patient monitoring.

Why Timing Matters: The Science Behind Scheduling Psychotherapy After Ketamine

New insights: Should psychotherapy happen during the ketamine session, immediately after, or the following day?

Congressional Psychedelics Report Card: Who Supports and Opposes Legalization

Knowing which members of Congress will advance or block psychedelic medicine helps advocates know where to focus their energy.

Doctor Receives 30 Months in Matthew Perry Ketamine Case

Dr. Salvador Plasencia became the first person sentenced in connection with actor Matthew Perry's 2023 ketamine overdose death.

Survey: 1.6 Million Americans Received Ketamine Treatment Last Year

A major new survey found that 1.6 million American adults received ketamine treatment in a supervised medical facility last year.

Exploding Head Syndrome: Ketamine Shows Promise for Rare Sleep Disorder

A man suffering from exploding head syndrome for over five years found relief through an unexpected treatment: sublingual ketamine.

Chinese Scientists Unlock the Mystery Behind Ketamine’s Rapid Relief for Depression

Chinese researchers have discovered a breakthrough that could transform the way ketamine can treat depression.

Cleveland Clinic Study Validates Low Dose Ketamine for Chronic Pain

Cleveland Clinic has published the largest study to date examining low dose ketamine infusions for chronic refractory pain.

FDA Program Promises to End Years of Ketamine Shortages for Mental Health Clinics

Phlow Corp. has been selected for the FDA's inaugural Commissioner's National Priority Voucher Pilot Program to manufacture ketamine's active pharmaceutical ingredient domestically.